A Phase I/II Clinical Trial Assessing Safety and Efficacy of BZL101 For Metastatic Breast Cancer.
Phase of Trial: Phase I
Latest Information Update: 15 Mar 2012
At a glance
- Drugs BZL 101 (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions; Therapeutic Use
- 15 Mar 2012 Actual patient number 27 added as reported by ClinicalTrials.gov.
- 15 Mar 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Jan 2010 Results presented in a Bionovo media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History